An association study of 43 SNPs in 16 candidate genes with atorvastatin response (Q46653214)

24 December 2017

title

An association study of 43 SNPs in 16 candidate genes with atorvastatin response (English)

1 reference

24 December 2017

author

John F Thompson

1

1 reference

24 December 2017

author name string

Man M

2

1 reference

24 December 2017

Johnson KJ

3

1 reference

24 December 2017

Wood LS

4

1 reference

24 December 2017

Lira ME

5

1 reference

24 December 2017

Lloyd DB

6

1 reference

24 December 2017

Banerjee P

7

1 reference

24 December 2017

Milos PM

8

1 reference

24 December 2017

Myrand SP

9

1 reference

24 December 2017

Paulauskis J

10

1 reference

24 December 2017

Milad MA

11

1 reference

24 December 2017

Sasiela WJ

12

1 reference

24 December 2017

publication date

1 January 2005

1 reference

24 December 2017

The Pharmacogenomics Journal

published in

1 reference

24 December 2017

volume

5

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

352-358

1 reference

24 December 2017

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Pharmacogenetic study of statin therapy and cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Sequence variation in the human angiotensin converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

An Alternative Fast and Convenient Genotyping Method for the Screening of Angiotensin Converting Enzyme Gene Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Genetic associations in large versus small studies: an empirical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Interpretation of genetic association studies in complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Pharmacogenetics of oral anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Polymorphisms in the CETP gene and association with CETP mass and HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Effect of apolipoprotein E polymorphism and XbaI polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non-familial hypercholesterolaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Lipid-lowering response to statins is affected by CYP3A5 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

The -514C/T polymorphism of the hepatic lipase gene significantly modulates the HDL-cholesterol response to statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

The pharmacogenetics of codeine hypoalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

inferred from DOI database lookup

7 January 2021

based on heuristic

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500328

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.TPJ.6500328

1 reference

24 December 2017

1 reference

24 December 2017